mifepristone
Drug
GenBioPro, Inc.
Total Payments
$38,400
Transactions
1
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $38,400 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $38,400 | 1 | 100.0% |
Top Doctors Receiving Payments for mifepristone
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Gynecology | Phoenix, AZ | $38,400 | 1 |
Ad
Manufacturing Companies
- GenBioPro, Inc. $38,400
Product Information
- Type Drug
- Total Payments $38,400
- Total Doctors 1
- Transactions 1
About mifepristone
mifepristone is a drug associated with $38,400 in payments to 1 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is GenBioPro, Inc..
Payment data is available from 2023 to 2023. In 2023, $38,400 was paid across 1 transactions to 1 doctors.
The most common payment nature for mifepristone is "Consulting Fee" ($38,400, 100.0% of total).